Acadia Pharmaceuticals buy Cantor Fitzgerald
Start price
02.02.24
/
50%
€23.60
Target price
02.02.25
€38.87
Performance (%)
-40.57%
Price
24.05.24
€14.03
Summary
This prediction is currently active. Massive losses of -40.57% have been the result for the BUY prediction by Cantor_Fitzgerald. This prediction currently runs until 02.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 3.163% | 3.163% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $42.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€34.35
09.05.25
09.05.25
-3.87%
24.05.24
24.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.79
30.04.24
30.04.24
€34.52
30.04.25
30.04.25
-8.99%
24.05.24
24.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
10.04.24
10.04.24
€34.38
10.04.25
10.04.25
-15.00%
24.05.24
24.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
28.02.24
28.02.24
€38.75
28.02.25
28.02.25
-35.67%
24.05.24
24.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€25.60
14.12.23
14.12.23
€38.21
14.12.24
14.12.24
-45.21%
24.05.24
24.05.24